The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Open Targets Platform: new developments and updates two years on
Open accessAbstract
The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification. The associations are displayed in an intuitive user interface (https://www.targetvalidation.org), and are available through a REST-API (https://api.opentargets.io/v3/platform/docs/swagger-ui) and a bulk download (https://www.targetvalidation.org/downloads/data). In addition to target-disease associations, we also aggregate and display data at the target and disease levels to aid target prioritisation. Since our first publication two years ago, we have made eight releases, added new data sources for target-disease associations, started including causal genetic variants from non genome-wide targeted arrays, added new target and disease annotations, launched new visualisations and improved existing ones and released a new web tool for batch search of up to 200 targets. We have a new URL for the Open Targets Platform REST-API, new REST endpoints and also removed the need for authorisation for API fair use. Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
ClinVar: improving access to variant interpretations and supporting evidence
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1153 · Cited by 4,196 · cited 5×
“These correspond to the (i) inclusion of targeted genotyping arrays from the GWAS Catalogue (12); (ii) addition of the new tier 2 cancer genes (13) from the Cancer Gene Census (14); (iii) coverage of trinucleotide repeat data from ClinVar (15) available in the European Variation Archive (https://www.ebi.ac.uk/eva/?Hom…”
BackgroundMethodInfluentialGenetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161
COSMIC: somatic cancer genetics at high-resolution
Forbes, S. A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C. G., Ward, S., Dawson, E., Ponting, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1121 · Cited by 1,922
Foundations of Multidimensional and Metric Data Structures
Samet, H., & Gray, J. (2006) · Cited by 1,612
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597 · cited 2×
“This census has recently introduced new criteria to assess the level of evidence that supports a gene as a driver gene in cancer, which leads to the concept of a tier system (13).”
BackgroundMethodSelf-citationA Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics
Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A.-K., Amini, B., Andersen, E., Andersson, A.-C., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,540
Database resources of the National Center for Biotechnology Information
Coordinators, N. R., Agarwala, R., Barrett, T., Beck, J., Benson, D. A., Bollin, C., Bolton, E., Bourexis, D., Brister, J. R., Bryant, S. H., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1095 · Cited by 1,502
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes
Pinero, J., Queralt-Rosinach, N., Bravo, A., Deu-Pons, J., Bauer-Mehren, A., Baron, M., Sanz, F., & Furlong, L. I. (2015) · Database · doi:10.1093/database/bav028 · Cited by 1,124
Perturbation-response genes reveal signaling footprints in cancer gene expression
(2017) · doi:10.1038/s41467-017-02391-6 · Cited by 1,108
Denny, J. C., Bastarache, L., Ritchie, M. D., Carroll, R. J., Zink, R., Mosley, J. D., Field, J. R., Pulley, J. M., Ramirez, A. H., Bowton, E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2749 · Cited by 1,013
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
The Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N. A., Engelstad, M., Foster, E., McMurry, J., Aymé, S., Baynam, G., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 754
OmniPath: guidelines and gateway for literature-curated signaling pathway resources
Türei, D., Korcsmáros, T., & Saez-Rodriguez, J. (2016) · Nature Methods · doi:10.1038/nmeth.4077 · Cited by 687
An Improved Non-monotonic Transition System for Dependency Parsing
Honnibal, M., & Johnson, M. (2015) · Proceedings of the 2015 Conference on Empirical Methods in Natural Language Processing · doi:10.18653/v1/d15-1162 · Cited by 602
Modeling sample variables with an Experimental Factor Ontology
Malone, J., Holloway, E., Adamusiak, T., Kapushesky, M., Zheng, J., Kolesnikov, N., Zhukova, A., Brazma, A., & Parkinson, H. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq099 · Cited by 568
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
Tamborero, D., Rubio-Perez, C., Deu-Pons, J., Schroeder, M. P., Vivancos, A., Rovira, A., Tusquets, I., Albanell, J., Rodon, J., Tabernero, J., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0531-8 · Cited by 519
Open Targets: a platform for therapeutic target identification and validation
Koscielny, G., An, P., Carvalho-Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1055 · Cited by 504
Self-citationPromise and pitfalls of the Immunochip
Cortes, A., & Brown, M. A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3204 · Cited by 479
Voight, B. F., Kang, H. M., Ding, J., Palmer, C. D., Sidore, C., Chines, P. S., Burtt, N. P., Fuchsberger, C., Li, Y., Erdmann, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002793 · Cited by 472
Expression Atlas: gene and protein expression across multiple studies and organisms
Papatheodorou, I., Fonseca, N. A., Keays, M., Tang, Y. A., Barrera, E., Bazant, W., Burke, M., Füllgrabe, A., Fuentes, A. M.-P., George, N., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1158 · Cited by 418
Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.14 · Cited by 378
Erratum: Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.52 · Cited by 311
Pharos: collating protein information to shed light on the druggable genome
Nguyen, D.-T., Mathias, S., Bologa, C., Brunak, S., Fernandez, N., Gaulton, A., Hersey, A., Holmes, J., Jensen, L. J., Karlsson, A., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1072 · Cited by 279
Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse
Smith, C. L., Blake, J. A., Kadin, J. A., Richardson, J. E., Bult, C. J., & the Mouse Genome Database Group (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1006 · Cited by 219
Caulfield, M. J., Davies, J., Dennys, M., Elbahy, L., Fowler, T., Hill, S., Hubbard, T., Jostins, L., Maltby, N., Mahon-Pearson, J., et al. (2017) · Figshare · doi:10.6084/m9.figshare.4530893 · Cited by 194
Locality-preserving hashing in multidimensional spaces
Indyk, P., Motwani, R., Raghavan, P., & Vempala, S. (1997) · ACM Symposium on Theory of Computing (STOC) · doi:10.1145/258533.258656 · Cited by 167
Standardized description of scientific evidence using the Evidence Ontology (ECO)
Chibucos, M. C., Mungall, C., Balakrishnan, R., Christie, K., Huntley, R. P., White, O. R., Blake, J. A., Lewis, S., & Giglio, M. G. (2014) · Database · doi:10.1093/database/bau075 · Cited by 103
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
Antolín, A. A., Tym, J. E., Komianou, A., Collins, I., Workman, P., & Al‐Lazikani, B. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.11.004 · Cited by 81
Levchenko, M., Gou, Y., Graef, F., Hamelers, A., Huang, Z., Ide‐Smith, M., Iyer, A., Kilian, O., Katuri, J., Kim, J.-H., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1005 · Cited by 36
Iorio, F., García‐Alonso, L., Brammeld, J. S., Martincorena, I., Willé, D. R., McDermott, U., & Sáez-Rodríguez, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25076-6 · Cited by 31
Computational resources associating diseases with genotypes, phenotypes and exposures
Zhang, W., Zhang, H., Yang, H., Li, M., Xie, Z., & Li, W. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby071 · Cited by 28
Designing an intuitive web application for drug discovery scientists
Karamanis, N., Carvalho‐Silva, D., Cham, J. A., Fumis, L., Hasan, S., Hulcoop, D. G., Koscielny, G., Maguire, M., Newell, W. R., Ong, C., et al. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.032 · Cited by 16
Self-citationBradley, A. R., Echalier, A., Fairhead, M., Strain-Damerell, C. M., Brennan, P. E., Bullock, A. N., Burgess-Brown, N., Carpenter, E. P., Gileadi, O., Marsden, B. D., et al. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170051 · Cited by 15
Cited by
UniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372
“The ProtVista viewer has already been implemented by the Open Targets (43) and the Pharos (44) databases of unstudied and understudied drug targets amongst others.”
MethodArtificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
““OpenTargets” (https:// www. opent argets. org/) [374], a freeware and ML-based tool, used for prioritizing potential therapeutic drug targets with over 71% accuracy.”
MethodRNA-binding proteins in human genetic disease
Gebauer, F., Schwarzl, T., Valcárcel, J., & Hentze, M. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00302-y · Cited by 1,176
BIOPEP-UWM Database of Bioactive Peptides: Current Opportunities
Minkiewicz, P., Iwaniak, A., & Darewicz, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235978 · Cited by 958
Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794
Metadata
- Authors
- Carvalho-Silva, D., Pierleoni, A., Pignatelli, M., Ong, C., Fumis, L., Karamanis, N., Carmona, M., Faulconbridge, A., Hercules, A., McAuley, E., Miranda, A., Peat, G., Spitzer, M., Barrett, J., Hulcoop, D. G., Papa, E., Koscielny, G., & Dunham, I.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-20
- Volume
- 47
- Issue
- D1
- Pages
- D1056-D1065
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2900668971
- Cited by
- 472
- References
- 41
- FWCI
- 45.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.